繁體
  • 简体中文
  • 繁體中文

熱門資訊> 正文

SIGA Technologies Wins $9 Million Antiviral Drug Procurement Contract From Defense Department

2024-08-22 04:47

04:47 PM EDT, 08/21/2024 (MT Newswires) -- SIGA Technologies (SIGA) said Wednesday it received a roughly $9 million order from the US Department of Defense for its antiviral drug TPOXX, also known as tecovirimat.

The order comprises mainly oral TPOXX and a small amount of intravenous TPOXX intended to protect military personnel against orthopoxvirus risks, such as smallpox, the pharmaceutical company said.

SIGA said the procurement contract award is its third from the defense department over the past three years.

Price: 10.43, Change: +0.61, Percent Change: +6.21

風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。